Clinical trials / NCT05975905
NCT05975905Phase 2Terminated

A Study to Investigate the Safety and Efficacy of KER-012 in Combination With Background Therapy in Adult Participants With Pulmonary Arterial Hypertension (PAH) (TROPOS Study).

Study sponsor: Keros Therapeutics, Inc. · KROS

Compare the available registry edits below. Primary completion is the date data collection ends for the main study measures; it does not tell you when results will be published.

Open ClinicalTrials.gov recordCSV export · Pro
Primary completion2025-03-05Actual
Enrollment · participants113Actual
Source updated2026-07-02Last update listed in the registry record
Version history

Changes to this trial

Last 12 months
Pro unlocks the full available history and CSV export. View Pro features

· 1 field changed

Recruitment status changed

− Before

Completed

+ After

Terminated

Check registry source

· 1 field changed

Main study measure wording changed

Text changed; whether the study measures changed has not been verified. Saved text may be shortened.

Compare wording
− Before

Measure: Change from Baseline in PVR (Pulmonary Vascular Resistance)

+ After

Measure: Change From Baseline in PVR (Pulmonary Vascular Resistance)

Check registry source